On 17 October 2025, Zhong Ji Longevity Science Group Limited (Stock Code: 767) announced the resignation of two executive directors, effective immediately. According to the announcement, Mr. Yan Yifan, who also stepped down as Chief Executive Officer, and Ms. Cao Xie Qiong both resigned to devote more time to personal and other business commitments. They confirmed there was no disagreement with the board and no additional matters needing to be brought to shareholder attention.

Mr. Yan Li, an existing executive director, has been appointed as the new Chief Executive Officer, effective the same date. He also serves as the chairman of the board, which means the roles of chairman and CEO are held by the same individual. The announcement noted that this arrangement deviates from a specific provision of the Corporate Governance Code, but it was considered appropriate given current circumstances and the overall balance of the board.

Mr. Yan Li, aged 54, joined the company as an executive director in November 2020. He has substantial management experience in advanced medical and biological technology fields and is beneficially interested in approximately 14.87% of the company’s issued shares. His annual remuneration under the appointment is HK$1,200,000, determined based on qualifications, responsibilities, and market factors.

The board of Zhong Ji Longevity Science Group Limited currently consists of two executive directors, two non-executive directors, and three independent non-executive directors. No other matters regarding these senior management changes were noted in the announcement.